To catalyze a global shift toward open,
incentive-aligned science—where innovation is faster and fairer by design.
Science innovation is slow. We’re fixing the capital stack.
BioVergence operates at the intersection of life-science development, scientific capital markets, and AI- native infrastructure. We help transform scientific assets into structured, financeable opportunities while building the intelligence layer that makes better financing and better science possible.
Biotech value is created at the asset level
250+ years
Combined team/advisor experience across R&D, commercialization, finance, and strategy.
Capital formation happens at the company level
$20M+
Capital and IP contributed by team and advisors to BioVergence.
BioVergence bridges the gap
500+ deals
Across R&D, commercialization, venture, PE, M&A, and strategic transactions.
Digital securities turn a right — intellectual property, a royalty stream, a milestone payment, a share of a program — into a digital instrument that can be owned, tracked, and transferred
Our Team
Digital assets can be used to manage rights related to
IP portfolios
Royalties
Milestones
Biosimilars
Clinical-stage assets
Platform technologies
Data assets
Manufacturing rights
Community-generated assets
Community Intelligence Network
We're building a contributor Community that helps source and shape insight into the future of science — starting with GLP-1 and longevity. Insights & community data may lead to in-house research, external asset tokenization, investment & prediction opportunities, and community rewards.
Our Story
Ushering in the age of bioconvergence
Science is full of brilliance, but it is and has been held back by broken systems.
In labs around the world, breakthroughs sit dormant. Intellectual property gathers dust. Funding flows unevenly. Scientists are stuck in legacy silos. Licensing is slow, opaque, and often extractive. And despite historic advancements in technology, most research struggles to make it out of PDFs , let alone into products or public hands.
At BioVergence, we saw this gap not just as a flaw, but as an opportunity. Why not make intellectual assets recombinable? Why not make research and data sets remixable? We set out to build an entirely new engine for scientific innovation—one rooted in openness, modularity, and decentralization.
Today, BioVergence is home to a growing ecosystem of frontier ventures, tokenized assets, and contributor-powered science. We’re not just accelerating innovation, we’re changing who gets to participate in it, who gets rewarded by it, and how fast it reaches the world.
.svg)
Our Values
Modular by Design
We build systems, assets, and communities to be flexible, remixable, and future-proof.
Science as Infrastructure
We treat knowledge as a building block, not a byproduct--ready to scale, combine, and deploy.
Incentive Drives Impact
We align rewards with contribution, ensuring value flows to those who create it.